IL15 and lung carcinoma: Given that several NSCLC cell lines show some resistance to DNT-mediated cytolysis (Table 1), and lung cancer xenograft growth was modestly inhibited by DNTs, we determined whether IL-15, a well-known myeloid derived immune modulator [23], could augment DNT-mediated anti-tumor activity.